Showing results (171-180 of 212) with videos related to

Sort By:
Pageof 22
Oncotarget|January 31, 2015
Molecular architecture of the ErbB2 extracellular domain homodimerShi Hu, Yuna Sun, Yanchun Meng, et al.
Cancer Letters|September 10, 2010
A bispecific antibody effectively inhibits tumor growth and metastasis by simultaneous blocking vascular endothelial growth factor A and osteopontinGeng Kou, Jingping Shi, Lin Chen, et al.
Mabs|April 7, 2016
Characterization of alanine to valine sequence variants in the Fc region of nivolumab biosimilar produced in Chinese hamster ovary cellsYantao Li, Tuo Fu, Tao Liu, et al.
Cancer Immunology, Immunotherapy : CII|August 20, 2009
A humanized anti-osteopontin antibody inhibits breast cancer growth and metastasis in vivoJianxin Dai, Bohua Li, Jinping Shi, et al.
Mini Reviews in Medicinal Chemistry|March 9, 2013
The finely regulating well-defined functional polymeric nanocarriers for anti-tumor immunotherapyWei Li, Li Zhang, Ge Zhang, et al.
Communications Biology|March 4, 2026
Mechanistic insights into the structure and function of the RecA C-terminal tailLu Su, Xiaofan Li, Feifan Wang, et al.
Cancer Gene Therapy|May 7, 2005
Treatment of hepatocellular carcinoma with adenoviral vector-mediated Flt3 ligand gene therapyHao Wang, Jianxin Dai, Sheng Hou, et al.
Arthritis and Rheumatism|June 26, 2008
Treatment of collagen-induced arthritis with an anti-osteopontin monoclonal antibody through promotion of apoptosis of both murine and human activated T cellsKexing Fan, Jianxin Dai, Hao Wang, et al.
Blood|November 2, 2013
Eradication of non-Hodgkin lymphoma through the induction of tumor-specific T-cell immunity by CD20-Flex BiFPLei Zhao, Qin Tong, Weizhu Qian, et al.
Cancer Gene Therapy|January 29, 2005
Murine mammary adenocarcinoma cells transfected with p53 and/or Flt3L induce antitumor immune responsesHongxun Sang, Vladimir M Pisarev, Jennifer Chavez, et al.
Pageof 22